Cost of Illness Study in MS
Research type
Research Study
Full title
Cost of Illness Study in Multiple Sclerosis
IRAS ID
161399
Contact name
Gisela Kobelt
Contact email
Sponsor organisation
MS Society
Duration of Study in the UK
1 years, 3 months, days
Research summary
This observational non-interventional study will provide European-wide information on resource consumption (and resulting costs) by people at different levels of severity of multiple sclerosis. All resources (medical and non-medical care, services, investments, production losses) will be included and valued. At the same time, overall quality of life (utility) will be collected and related to disease severity. The effect of relapses, fatigue, cognitive difficulties on costs will be investigated. Results will be presented from the societal perspective (all costs regardless of who ultimately pays), as well as from the perspective of the UK NHS/PSS.
The information will be collected directly from patients, using a specific questionnaire that can be completed as a paper version or on-line on a dedicated study site. The questionnaire and web-link will be made available by the National MS Society to its members, and answers are entirely anonymous. A minimum of 800-1000 patients, covering all levels of disease severity, will be included. Prior informed consent will be required.
Electronic data will be stored in a secure on-line database with access limited to appropriate personnel. Paper versions of the questionnaire will be manually entered into the database and then stored securely. All data will be stored in line with all local and national data protection regulations.REC name
North East - Tyne & Wear South Research Ethics Committee
REC reference
15/NE/0027
Date of REC Opinion
20 Jan 2015
REC opinion
Favourable Opinion